926 related articles for article (PubMed ID: 25747741)
1. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
[TBL] [Abstract][Full Text] [Related]
2. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
[TBL] [Abstract][Full Text] [Related]
4. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.
Sundberg M; Bogetofte H; Lawson T; Jansson J; Smith G; Astradsson A; Moore M; Osborn T; Cooper O; Spealman R; Hallett P; Isacson O
Stem Cells; 2013 Aug; 31(8):1548-62. PubMed ID: 23666606
[TBL] [Abstract][Full Text] [Related]
5. Intrastriatal transplantation of stem cells from human exfoliated deciduous teeth reduces motor defects in Parkinsonian rats.
Zhang N; Lu X; Wu S; Li X; Duan J; Chen C; Wang W; Song H; Tong J; Li S; Liu Y; Kang X; Wang X; Han F
Cytotherapy; 2018 May; 20(5):670-686. PubMed ID: 29576501
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of Induced Neural Stem Cells for Parkinson's Disease.
Choi DH; Kim JH; Kim SM; Kang K; Han DW; Lee J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117752
[TBL] [Abstract][Full Text] [Related]
7. Engraftable Induced Pluripotent Stem Cell-Derived Neural Precursors for Brain Repair.
Zygogianni O; Kouroupi G; Taoufik E; Matsas R
Methods Mol Biol; 2020; 2155():23-39. PubMed ID: 32474865
[TBL] [Abstract][Full Text] [Related]
8. Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion.
Yuan T; Liao W; Feng NH; Lou YL; Niu X; Zhang AJ; Wang Y; Deng ZF
Stem Cell Res Ther; 2013 Jun; 4(3):73. PubMed ID: 23769173
[TBL] [Abstract][Full Text] [Related]
9. Combined MSC-Secreted Factors and Neural Stem Cell Transplantation Promote Functional Recovery of PD Rats.
Yao Y; Huang C; Gu P; Wen T
Cell Transplant; 2016; 25(6):1101-13. PubMed ID: 26607204
[TBL] [Abstract][Full Text] [Related]
10. Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson's disease.
Zhao Y; Xi G
Pharm Biol; 2018 Dec; 56(1):450-454. PubMed ID: 30354840
[TBL] [Abstract][Full Text] [Related]
11. Neural stem cells transplantation combined with ethyl stearate improve PD rats motor behavior by promoting NSCs migration and differentiation.
Huang J; Yi L; Yang X; Zheng Q; Zhong J; Ye S; Li X; Li H; Chen D; Li C
CNS Neurosci Ther; 2023 Jun; 29(6):1571-1584. PubMed ID: 36924304
[TBL] [Abstract][Full Text] [Related]
12. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
Kim HW; Lee HS; Kang JM; Bae SH; Kim C; Lee SH; Schwarz J; Kim GJ; Kim JS; Cha DH; Kim J; Chang SW; Lee TH; Moon J
Cell Transplant; 2018 May; 27(5):814-830. PubMed ID: 29871515
[TBL] [Abstract][Full Text] [Related]
13. Understanding Parkinson's Disease through the Use of Cell Reprogramming.
Playne R; Connor B
Stem Cell Rev Rep; 2017 Apr; 13(2):151-169. PubMed ID: 28083784
[TBL] [Abstract][Full Text] [Related]
14. Co-transplantation of autologous T
Park TY; Jeon J; Lee N; Kim J; Song B; Kim JH; Lee SK; Liu D; Cha Y; Kim M; Leblanc P; Herrington TM; Carter BS; Schweitzer JS; Kim KS
Nature; 2023 Jul; 619(7970):606-615. PubMed ID: 37438521
[TBL] [Abstract][Full Text] [Related]
15. Survival and engraftment of dopaminergic neurons manufactured by a Good Manufacturing Practice-compatible process.
Peng J; Liu Q; Rao MS; Zeng X
Cytotherapy; 2014 Sep; 16(9):1305-12. PubMed ID: 25065637
[TBL] [Abstract][Full Text] [Related]
16. MRI Tracking of iPS Cells-Induced Neural Stem Cells in Traumatic Brain Injury Rats.
Jiang L; Li R; Tang H; Zhong J; Sun H; Tang W; Wang H; Zhu J
Cell Transplant; 2019 Jun; 28(6):747-755. PubMed ID: 30574806
[TBL] [Abstract][Full Text] [Related]
17. Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson's Disease Drug Development.
Antonov SA; Novosadova EV
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806103
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats.
Cai J; Yang M; Poremsky E; Kidd S; Schneider JS; Iacovitti L
Stem Cells Dev; 2010 Jul; 19(7):1017-23. PubMed ID: 19824823
[TBL] [Abstract][Full Text] [Related]
19. Liver growth factor promotes the survival of grafted neural stem cells in a rat model of Parkinson's disease.
Reimers D; Osuna C; Gonzalo-Gobernado R; Herranz AS; Diaz-Gil JJ; Jimenez-Escrig A; Asensio MJ; Miranda C; Rodriguez-Serrano M; Bazan E
Curr Stem Cell Res Ther; 2012 Jan; 7(1):15-25. PubMed ID: 21190529
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model.
Yuan Y; Tang X; Bai YF; Wang S; An J; Wu Y; Xu ZD; Zhang YA; Chen Z
Theranostics; 2018; 8(17):4679-4694. PubMed ID: 30279731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
